Featured News
-
When Is the Right Time to Begin Treatment in CMT1A and CMT1E? -
Seven Reasons to Attend the CMTA Patient & Research Summit -
The Community We Needed, The Community We Built: Dear Younger Me -
CMTA-STAR Alliance Partner Vanda Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for CMT2S Therapy Candidate -
Walking Poles and CMT -
Is Spinal Fluid the Way to Gene Therapy in CMT? -
CMTA Leading the Way in CMT1A -
CMTA research takes the stage at PNS -
What Filspari Means for People with CMTDIE
All News
Search Simply CMT by Category
-
When Is the Right Time to Begin Treatment in CMT1A and CMT1E?
What if the timing of treatment could change everything? CMTA is funding a new study…
Published: September 4, 2026
-
Seven Reasons to Attend the CMTA Patient & Research Summit
Need a reason to go to the CMTA Patient & Research Summit in San Francisco…
Published: August 20, 2026
-
CMT1B and CMT1E Research: Can Existing Drugs Treat Nerve Damage?CMT1B and CMT1E can take away strength, feeling, and balance from damage to the nerve…
Published: August 10, 2026
-
Shaping CMT Clinical TrialsCMTA is leading efforts to improve CMT clinical trials through new recommendations that help create…
Published: August 5, 2026
-
The Community We Needed, The Community We Built: Dear Younger Me
Footprint Fellowship mentors reflect on growing up with CMT and share the advice and hope…
Published: August 3, 2026
-
CMTA-STAR Alliance Partner Vanda Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for CMT2S Therapy Candidate
CMTA Strategy to Accelerate Research (CMTA-STAR) Alliance Partner Vanda Pharmaceuticals has announced that the U.S. Food…
Published: July 9, 2026
-
Walking Poles and CMT
Travel means more time on your feet, navigating new terrain like cobblestones, stairs, gravel, or uneven pavement.…
Published: July 9, 2026
-
Is Spinal Fluid the Way to Gene Therapy in CMT?
Most kinds of CMT come from a problem in a single gene. Repairing that faulty…
Published: July 9, 2026
-
CMTA Leading the Way in CMT1A
CMTA is leading a coordinated CMT1A research strategy that connects disease models, drug development, biomarkers,…
Published: July 8, 2026
-
CMTA research takes the stage at PNS
PNS 2026 showcased CMTA’s role in advancing CMT research across the translational pipeline, from biomarkers…
Published: July 8, 2026
-
What Filspari Means for People with CMTDIE
FDA approval of Filspari creates a new treatment option for FSGS that may benefit some…
Published: July 8, 2026
-
New CMT1A Assay Now AvailableCMTA expands its Preclinical Toolbox with a new CMT1A assay, providing researchers with a human-relevant…
Published: July 8, 2026
